NeuroBionics
MJ Antonini is the Co-Founder and CEO of NeuroBionics, a company dedicated to expanding access to neuromodulation therapy by enabling Deep-Brain-Stimulation without the need for open brain surgery, since June 2023. Prior to this role, MJ served as a Postdoctoral Researcher at the Massachusetts Institute of Technology from September 2015 to December 2023, focusing on the development and translation of multifunctional probes for interfacing with the peripheral nervous system and gastrointestinal muscles. MJ has a comprehensive educational background, including two PhDs in Health Sciences and Technology from Harvard Medical School and the Massachusetts Institute of Technology, as well as multiple advanced degrees in neuroscience, bioengineering, and mechanical engineering. MJ's research experience spans various prestigious institutions, including significant projects related to neuronal dysfunction in Huntington Disease and the development of assistive technologies for quadriplegic patients.
This person is not in any teams
This person is not in any offices
NeuroBionics
NeuroBionics is pioneering the future of precision bioelectronic medicine by developing the next generation of implantable devices, designed to seamlessly interface with the human body. Our core technology lies in flexible, multifunctional fibers the size of a human hair, which can record and stimulate neural activity, deliver drugs, and ablate tissue. Using an endovascular approach, we will navigate our microscopic-sized flexible fiber implant through the intricate network of blood vessels to deliver precise therapeutic intervention to neural tissue. By making neural interfacing a minimally-invasive procedure, we will revolutionize deep brain stimulation and broaden access to this lifechanging therapy. By doing so, we aim to improve the lives of millions grappling with conditions like Parkinson's disease, essential tremor, epilepsy, and depression.